Profile

JN Nova Pharma is Canadian biotech company which has worked with National Research Council of Canada Human-Health scientists to develop promising therapeutics for unmet medical needs. JN Nova Pharma is poised to deliver a transformative therapeutic platform targeting Long COVID, ARDS, AKI and IPF. With a strong scientific foundation, global IP, and strategic collaborations, we are well-positioned to enter clinical trial in Q42025 and commercial partnerships by late 2026/27.

JN Nova Pharma Inc. logo

Website

jnnova.com

Contact


Event details

Date: November 3 - 5, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

22 in total